[Breaking] HLB Shares Fall to 40,000-Won Range... HLB Life Science Stock Plunges 11%, All 10 Affiliated Stocks Weaken
HLB-related stocks fell across the board during the morning session on the 15th. HLB Biostep led the decline with a drop of around 11%, while losses also widened for affiliated stocks such as HLB Therapeutics and HLB Pharmaceutical, drawing market attention. As of that morning, HLB was trading at 4
![[Breaking] HLB Shares Fall to 40,000-Won Range... HLB Life Science Stock Plunges 11%, All 10 Affiliated Stocks Weaken](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F09%2F604784%2F7d11344647c6914a%2Foriginal.webp&w=1920&q=75)
HLB-related stocks fell across the board during the morning session on the 15th. HLB Biostep led the decline with a drop of around 11%, while losses also widened for affiliated stocks such as HLB Therapeutics and HLB Pharmaceutical, drawing market attention.
As of that morning, HLB was trading at 40,750 won, down 1,250 won from the previous day, a decline of 2.98%. The opening price was 41,800 won, which was also the intraday high, and the stock slipped to as low as 40,050 won during the session.
Among the affiliated stocks, HLB Biostep posted the largest drop. It fell 11.48% to 5,010 won, down 650 won from the previous day, with an intraday low of 4,900 won, dipping below the 5,000-won level.
HLB Therapeutics also weakened, falling 9.20% to 2,615 won, down 265 won from the previous day, while HLB Pharmaceutical fell 8.00% to 10,470 won, down 910 won.
In addition, HLB Global dropped 6.10% to 1,939 won and HLB Genex fell 6.08% to 2,085 won. HLB Life Science traded 5.75% lower at 3,605 won, HLB Pep declined 4.35% to 4,180 won, HLB Panagine fell 4.21% to 1,342 won, and HLB Innovation dropped 3.10% to 16,890 won. As a result, all 10 HLB-related stocks recorded losses.
Around the same time, other major bio stocks were also mostly sluggish. Oriex fell 7.12% to 848,000 won, ABL Bio declined 6.15% to 404,500 won, and Alteogen dropped 5.12% to 2.13 million won. In contrast, Samsung Biologics rose 2.20% to 1.208 million won and Peptoron gained 0.78% to 90,100 won, showing mixed price movements among bio sector stocks.
It remains to be seen whether the simultaneous decline in HLB-related stocks will prove to be a temporary intraday price correction or whether the weakness will continue.
[This article was written based on intraday market information and does not constitute an investment recommendation for any specific stock. Stock prices are subject to real-time fluctuations, and the movement of individual stocks does not definitively indicate a company's business performance or future stock price direction. Investment decisions and responsibility rest with the investor, and AI assistance was used in writing this article.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.



